Literature DB >> 20062787

Lung metastasis 21 years after initial diagnosis of osteosarcoma: a case report.

Ari Halldorsson1, Steven Brooks, Sam Montgomery, Suzanne Graham.   

Abstract

INTRODUCTION: To the best of our knowledge, this case report describes the longest disease-free interval between primary diagnosis and metastatic recurrence of an osteosarcoma. CASE
PRESENTATION: A 35-year-old Caucasian American man presented with asymptomatic lung metastases 21 years after being diagnosed and treated for lower extremity osteosarcoma. He underwent curative lung resection, but 2 years thereafter developed metastatic disease in the scapula and tibia and, after resection and chemotherapy, is in remission 1 year later.
CONCLUSION: This case highlights the importance of long follow-up periods and continued surveillance of osteosarcoma patients after initial curative treatment.

Entities:  

Year:  2009        PMID: 20062787      PMCID: PMC2803821          DOI: 10.1186/1752-1947-3-9298

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  8 in total

1.  Late relapse in osteosarcoma.

Authors:  Stefano Ferrari; Antonio Briccoli; Mario Mercuri; Franco Bertoni; Marilena Cesari; Alessandra Longhi; Gaetano Bacci
Journal:  J Pediatr Hematol Oncol       Date:  2006-07       Impact factor: 1.289

2.  Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

Authors:  Stefan S Bielack; Beate Kempf-Bielack; Günter Delling; G Ulrich Exner; Silke Flege; Knut Helmke; Rainer Kotz; Mechthild Salzer-Kuntschik; Matthias Werner; Winfried Winkelmann; Andreas Zoubek; Heribert Jürgens; Kurt Winkler
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

3.  Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).

Authors:  Beate Kempf-Bielack; Stefan S Bielack; Heribert Jürgens; Detlev Branscheid; Wolfgang E Berdel; G Ulrich Exner; Ulrich Göbel; Knut Helmke; Gernot Jundt; Hartmut Kabisch; Mathias Kevric; Thomas Klingebiel; Rainer Kotz; Rainer Maas; Rudolf Schwarz; Michael Semik; Jörn Treuner; Andreas Zoubek; Kurt Winkler
Journal:  J Clin Oncol       Date:  2005-01-20       Impact factor: 44.544

Review 4.  Osteosarcoma: basic science and clinical implications.

Authors:  James B Hayden; Bang H Hoang
Journal:  Orthop Clin North Am       Date:  2006-01       Impact factor: 2.472

5.  Local recurrence of parosteal osteosarcoma adjacent to a prosthesis after 20 years: a case report.

Authors:  T W Lau; J W K Wong; D K H Yip; E P Chien; T W H Shek; L L S Wong
Journal:  J Orthop Surg (Hong Kong)       Date:  2004-12       Impact factor: 1.118

6.  Late relapse of osteosarcoma: implications for follow-up and screening.

Authors:  Sandra J Strauss; Anne McTiernan; Jeremy S Whelan
Journal:  Pediatr Blood Cancer       Date:  2004-11       Impact factor: 3.167

7.  Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.

Authors:  Douglas S Hawkins; Carola A S Arndt
Journal:  Cancer       Date:  2003-12-01       Impact factor: 6.860

8.  Recurrences following primary osteosarcoma in adolescents and adults previously treated with chemotherapy.

Authors:  F Duffaud; L Digue; C Mercier; J P Dales; M Baciuchka-Palmaro; F Volot; P Thomas; R Favre
Journal:  Eur J Cancer       Date:  2003-09       Impact factor: 9.162

  8 in total
  6 in total

1.  An Atypical Behavior of Metastatic Lung Disease in a Young Woman With Osteosarcoma: A Case Report.

Authors:  Anaïs Acquisto; Ivan Duran Derijckere; Riccardo De Angelis
Journal:  Cureus       Date:  2022-01-25

Review 2.  Overcoming Therapeutic Resistance of Bone Sarcomas: Overview of the Molecular Mechanisms and Therapeutic Targets for Bone Sarcoma Stem Cells.

Authors:  Tomohiro Fujiwara; Toshifumi Ozaki
Journal:  Stem Cells Int       Date:  2016-12-27       Impact factor: 5.443

3.  miR-486 suppresses the development of osteosarcoma by regulating PKC-δ pathway.

Authors:  Ming He; Guangbin Wang; Linlin Jiang; Chuang Qiu; Bin Li; Jiashi Wang; Yonghui Fu
Journal:  Int J Oncol       Date:  2017-03-22       Impact factor: 5.650

Review 4.  Target Therapies for Uterine Carcinosarcomas: Current Evidence and Future Perspectives.

Authors:  Salvatore Giovanni Vitale; Antonio Simone Laganà; Stella Capriglione; Roberto Angioli; Valentina Lucia La Rosa; Salvatore Lopez; Gaetano Valenti; Fabrizio Sapia; Giuseppe Sarpietro; Salvatore Butticè; Carmelo Tuscano; Daniele Fanale; Alessandro Tropea; Diego Rossetti
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

Review 5.  Biological evidence of cancer stem-like cells and recurrent disease in osteosarcoma.

Authors:  Camille Jubelin; Javier Muñoz-Garcia; Denis Cochonneau; Emilie Moranton; Marie-Françoise Heymann; Dominique Heymann
Journal:  Cancer Drug Resist       Date:  2022-02-16

Review 6.  Very late relapse of high-grade osteosarcoma: A case report and review of the literature.

Authors:  Yoichi Kaneuchi; Michiyuki Hakozaki; Hitoshi Yamada; Osamu Hasegawa; Shoki Yamada; Yuka Oka; Kazuo Watanabe; Shinichi Konno
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.